Institute of Biomedical Research Inc (OTCMKTS:MRES) Stock Extends Rally: Here is Why

It is quite likely that the Institute of Biomedical Research Inc (OTCMKTS:MRES) stock is going to come on to the radars of investors this morning after it emerged as a notable gainer and ended up with gains of as much as 14% following a development. The biotech firm, which is involved on alternative plant-based CBD and research into mental health, came up with an update yesterday.

Market Action

On Thursday, MRES stock increased 13.89% to $0.0123 with more than 1.94 million shares, compared to volume of 326.34K shares. The stock moved within a range of $0.0104 – 0.0125 after opening trade at $0.0104.

M2Bio Opens Bangkok Office and Appoints Managing Director

The company announced yesterday that it opened a new corporate office in Bangkok in Thailand. Jade Sirisompan, who is the freshly appointed Managing Director at Institute of Biomedical Research, would be heading up those operations. Sirisompan holds a master’s degree in psychology and worked in the mental health space over the course of the past couple of years.

It was a significant new announcement from Institute of Biomedical Research yesterday and the price action in the stock was in indication of the fact that the investors were on board with the move. In addition to that, Sirisompan also holds considerable experience in the fitness and Muay Thai industries in the capacity of a former fighting professional and champion. It could well be a good time to add the Institute of Biomedical Research stock to your watch lists.

Related Posts

About The Author